Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market
Holding ANRO?
Track your performance easily

Alto Neuroscience, Inc. (ANRO) Income Statement

94 Followers

Alto Neuroscience, Inc. Income Statement

Last quarter (Q2 2024), Alto Neuroscience, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q2, Alto Neuroscience, Inc.'s net income was $-16.03M. See Alto Neuroscience, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 30.11M$ 37.81M$ 29.19M
Operating Income
$ -30.11M$ -37.81M$ -29.19M
Net Non Operating Interest Income Expense
$ 3.04M$ 979.00K$ 114.00K
Other Income Expense
$ -166.00K$ -525.00K$ -2.11M
Pretax Income
$ -26.90M$ -36.30M$ -26.97M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -27.25M$ -36.30M$ -26.97M
Basic EPS
$ -3.57$ -9.73$ -8.04
Diluted EPS
$ -3.57$ -9.73$ -8.04
Basic Average Shares
$ 30.69M$ 3.73M$ 3.45M
Diluted Average Shares
$ 30.69M$ 3.73M$ 3.45M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 30.11M$ 37.81M$ 29.19M
Net Income From Continuing And Discontinued Operation
$ -27.25M$ -36.30M$ -26.97M
Normalized Income
$ -15.53M--
Interest Expense
---
EBIT
$ -16.03M--
EBITDA
$ -15.86M--
Currency in USD

Alto Neuroscience, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis